Cardax (OTCMKTS:CDXI) Issues Earnings Results

Cardax (OTCMKTS:CDXI) issued its quarterly earnings results on Friday. The company reported ($1.79) earnings per share (EPS) for the quarter, reports. The company had revenue of $0.07 million for the quarter.

CDXI stock opened at $1.74 on Monday. Cardax has a twelve month low of $1.40 and a twelve month high of $19.00. The business’s 50 day moving average is $2.44.

About Cardax

Cardax, Inc, a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an anti-inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity.

Featured Article: How to Invest in a Bull Market

Earnings History for Cardax (OTCMKTS:CDXI)

Receive News & Ratings for Cardax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardax and related companies with MarketBeat.com's FREE daily email newsletter.